Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-17
DOI
10.3389/fphar.2021.669642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
- (2020) Hui Luo et al. Chinese Journal of Integrative Medicine
- Coronavirus Disease COVID-19: A New Threat to Public Health
- (2020) Sumit Kumar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Outbreak: An Overview
- (2020) Marco Ciotti et al. CHEMOTHERAPY
- SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus
- (2020) Michele Costanzo et al. CURRENT MEDICINAL CHEMISTRY
- Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
- (2020) Lovika Mittal et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach
- (2020) Saurov Mahanta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
- (2020) Subramanian Boopathi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
- (2020) Phulen Sarma et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Discovery of M Protease inhibitors encoded by SARS-CoV-2
- (2020) Hui-Chen Hung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery
- (2020) Mahmoud A. A. Ibrahim et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study
- (2020) Rajesh Ghosh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
- (2020) Mahmoud Kandeel et al. LIFE SCIENCES
- In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2
- (2020) Saksham Garg et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
- (2016) Kesava Rao V. Kurapati et al. Frontiers in Microbiology
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started